SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

RAPT Therapeutics Posts Wider Q1 Loss

05/11/2021 05:18

09:07 AM EDT, 05/11/2021 (MT Newswires) -- RAPT Therapeutics (RAPT) on Tuesday reported a Q1 loss of $0.66 per share, compared with a loss of $0.56 per share a year earlier. The consensus estimate of analysts polled by Capital IQ was for a loss of $0.62 per share.

The clinical-stage biopharmaceutical company also reported revenue of $1.2 million for the March quarter, up from $0.9 million a year ago. Wall Street was looking for revenue of $0.7 million.

RAPT Therapeutics said it ended Q1 with $98.4 million of cash and cash equivalents and marketable securities.

Price: 19.91, Change: 0.00, Percent Change: 0.00